Pulse Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Pulse Biosciences generated cash of -$33,041,000, which is more than the previous year. Cash used in financing activities reached the amount of $16,388,000 last year. Net change in cash is therefore -$16,774,000.
Cash Flow
| 2014 | -173.14K | -77.14K | 12.26M |
|---|---|---|---|
| 2015 | -3.31M | -86.03K | 0 |
| 2016 | -8.05M | -14.38M | 20.91M |
| 2017 | -11.08M | -22.99M | 35.38M |
| 2018 | -23.89M | 26.11M | 45.49M |
| 2019 | -34.18M | -10.10M | 82K |
| 2020 | -35.36M | 10.04M | 30.88M |
| 2021 | -54.09M | 7.56M | 62.68M |
| 2022 | -47.01M | -401K | 79.93M |
| 2023 | -33.04M | -121K | 16.38M |
PLSE Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 61.13M | 28.61M | 12.46M | 6.89M | 51.10M | 3.38M | 2.08M | 3.60M | 7.00M | 0 |
Operating activities | ||||||||||
Net income | -42.21M | -58.50M | -63.66M | -49.85M | -46.97M | -37.54M | -25.56M | -9.51M | -2.81M | -474.85K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.20M | 1.35M | 1.14M | 1.09M | 1.16M | 1.31M | 1.00M | 759K | 716.98K | 200.57K |
Stock-based compensation expense | 7.18M | 5.19M | 14.60M | 10.07M | 11.28M | 0 | 10.92M | 870K | 402.09K | 0 |
| Deferred income tax benefit | 7.18M | 5.19M | 14.60M | 10.07M | 11.28M | 0 | 10.92M | 870K | 402.09K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 109K | 61K | -61K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | -2.65M | -5.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 263K | -1.30M | 1.16M | -266K | 646K | 490K | 517K | 3K | 124.73K | 0 |
Cash generated by operating activities | -33.04M | -47.01M | -54.09M | -35.36M | -34.18M | -23.89M | -11.08M | -8.05M | -3.31M | -173.14K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | -29.02M | -77.99M | -40.29M | -43.59M | -19.06M | 0 | 0 |
Investments In Property Plant And Equipment | -121K | -401K | -437K | -441K | -608K | -276K | -2.55M | -64K | -86.03K | -78.85K |
Acquisitions Net | 0 | 0 | 0 | -10.48M | 9.49M | 0 | 0 | 64K | 0 | 1.71K |
Cash generated by investing activities | -121K | -401K | 7.56M | 10.04M | -10.10M | 26.11M | -22.99M | -14.38M | -86.03K | -77.14K |
Financing activities | ||||||||||
Common Stock Issued | 16.39M | 14.86M | 56.69M | 30.88M | 695K | 0 | 34.84M | 20.91M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 395K | 0 | 810K | 0 | -613K | -115K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 65M | -1.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 16.38M | 79.93M | 62.68M | 30.88M | 82K | 45.49M | 35.38M | 20.91M | 0 | 12.26M |
Net Change In Cash | -16.77M | 32.52M | 16.15M | 5.56M | -44.20M | 47.71M | 1.29M | -1.51M | -3.40M | 12.01M |
Cash at end of period | 44.36M | 61.13M | 28.61M | 12.46M | 6.89M | 51.10M | 3.38M | 2.08M | 3.60M | 12.01M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |